Andrew Lacy is the Founder and CEO of Prenuvo, the company making proactive whole-body MRI scanning a mainstream healthcare tool. A Melbourne-born, Stanford-trained entrepreneur, he previously co-founded Tapulous - the mobile gaming company behind Tap Tap Revenge, acquired by Disney in 2010 - before pivoting to healthcare. At Prenuvo, he has raised $177M in total funding (including a $120M Series B in 2024), grown the company to 110,000+ members across 17 North American clinics, and secured FDA clearance for AI-powered body composition analysis, with plans to expand into Europe and Australia.
Doktor Gurson is the Co-founder and CEO of Rad AI, the leading generative AI platform for radiology, powering over 50% of U.S. health systems. A serial entrepreneur and Y Combinator alum, he started his first internet company at age 15 - a domain registrar that became the world's 32nd ICANN-accredited registrar. At Rad AI, which he co-founded in 2018 with radiologist Jeff Chang, he has built a $525M company that automates radiology report generation, reducing radiologist burnout while improving diagnostic accuracy across more than 200 hospitals and health systems.
Julián Ríos Cantú is the co-founder and CEO of Eden, the leading cloud-native radiology operating system in Latin America. Motivated by his mother's battle with breast cancer, he began building health technology at age 16, went on to become the youngest-ever winner of the Global Student Entrepreneur Awards at 18, earned a Thiel Fellowship, and went through Y Combinator in 2018. Today, Eden processes over 13 million diagnostic studies annually across 18 countries for more than 2,200 medical institutions, backed by Sierra Ventures, Khosla Ventures, Kaszek, and notable angel investors including Leonardo DiCaprio, Ashton Kutcher, and Tony Robbins.
Karim Karti is the CEO of RapidAI, a deep clinical AI company whose platform is used in 2,500+ hospitals across 100+ countries for stroke, vascular, and radiology workflows. He brings 22+ years from GE Healthcare — including running its $9B imaging division — and a stint as COO of iRhythm, where he doubled revenues to $210M in 18 months. Trained as an engineer in France and a former P&G brand manager, he now leads one of the most clinically validated AI platforms in medicine, backed by 700+ published studies and 10+ million scans processed.
Keith Carter is a healthcare technology operator with deep roots in medical imaging and surgical data infrastructure. Currently VP of Implementations & Integrations at Caresyntax - the AI-powered surgical intelligence platform used in 3,500+ operating rooms worldwide - he also serves as CEO of Cloud9PACS.com, a digital PACS system he built from the ground up. Carter's career traces the arc of healthcare IT: from PACS architect at Medlink to running his own imaging solutions company, to joining one of the most-funded surgical AI ventures in the industry. He is based in Hattiesburg, Mississippi.
Rad AI builds generative-AI software that drafts the most tedious parts of a radiology report - the impressions, the follow-ups, the boilerplate - so radiologists can spend more time on the images and less on the keyboard. Founded in 2018 by a radiologist (Jeff Chang) and a serial founder (Doktor Gurson), the company now works with roughly nine of the ten largest radiology groups in the U.S. and touches close to half of the country's medical imaging.
RapidAI builds FDA-cleared clinical AI software that reads CT, CTA, CT perfusion and MRI scans to flag stroke, aneurysms and pulmonary embolisms in minutes - giving hospital teams a faster path to treatment. The platform began life as the Stanford spin-out iSchemaView and now runs in more than 2,000 hospitals across 100+ countries.
Sirona Medical is a San Francisco cloud-native radiology software company building Unify, a single platform that fuses PACS, viewer, worklist, reporting and AI into one browser-based workflow for radiologists.
Promaxo builds the world's first single-sided, in-office MRI platform - a compact magnet, AI, and robotics stack that lets urologists run image-guided prostate biopsies and focal treatments in their own clinic, without a hospital scanner suite.
VELMENI is a Sunnyvale-based dental AI platform that uses computer vision and deep learning to analyze 2D and 3D dental radiographs in real time. Its FDA-cleared flagship product, VELMENI for DENTISTS, is the first dental AI approved to detect pathologies in panoramic X-rays — catching caries, bone loss, and other findings that experienced clinicians miss roughly one-third of the time. Beyond diagnostics, the platform automates insurance claims, enables voice-assisted periodontal charting, interprets CBCT scans, and delivers VR-based patient education, all from a single integrated workflow. Founded in 2020 by CEO Mini Suri and Chief Dental Officer Dr. Arvin Oberai, the company has been beta-tested by over 1,300 dentists across 500+ practices in 50+ countries.
Viz.ai is an AI-powered care coordination platform trusted by over 2,000 hospitals across the United States. The company's suite of 50+ FDA-cleared algorithms analyzes medical imaging data in real time - detecting strokes, brain hemorrhages, aneurysms, pulmonary embolisms, and cardiac conditions - then instantly alerts the right clinical team so treatment can begin minutes faster. Founded in 2016 by neurosurgeon Dr. Chris Mansi and machine learning researcher Dr. David Golan, Viz.ai has grown into a platform covering 230 million lives, supporting 70,000+ healthcare providers, and partnering with 14+ leading pharmaceutical companies to accelerate drug development and patient access.
Barton Wells is the co-founder, CEO, and CTO of DexaFit Dx, a Palo Alto-based health technology company using AI and full-body DXA scans to detect coronary artery disease, Type 2 diabetes, and other chronic conditions early and non-invasively. A Stanford-trained mathematician and former world-ranked open water marathon swimmer, Wells brings 30+ years of AI, computer vision, and iOS engineering experience - spanning stints at Dropbox and multiple startups - to the challenge of transforming a 7-minute medical scan into a multi-disease risk screening platform for insurers, employers, and individuals.
Nishith Khandwala (Nish) is the co-founder and CEO of Bunkerhill Health, a San Francisco-based AI company building the operating system for clinical action inside health systems. A Stanford computer scientist who started in AI labs with no healthcare background, he pivoted after physicians walked in with real clinical problems - and after his own father's heart attack forced him to ask why his coronary calcium AI wasn't reaching patients. Bunkerhill's Carebricks platform now powers 7+ clinical domains at major health systems including UTMB, HCA Florida, MedStar, and WVU Medicine. The company has raised $30.4M from Sequoia, Optum Ventures, and Y Combinator, earned multiple FDA clearances, and landed Nishith on Forbes 30 Under 30 and the inaugural Mayfield Divot AI List.
Chris Mansi is a Cambridge and UCL-trained neurosurgeon turned AI entrepreneur, and the Co-founder and CEO of Viz.ai - the company that puts an AI brain between a CT scanner and a surgeon so that patients who are about to die of a stroke stop dying from delays. Named to TIME100 AI in 2024, Mansi built Viz.ai from a Stanford dorm-room insight into a platform covering nearly 2,000 U.S. hospitals and 230 million lives, reducing stroke diagnostic timelines by more than an hour - one patient at a time, every ten seconds.
Dr. Prithipal S. Sethi is a board-certified urologist, founder and CEO of Golden State Urology, and Chief Medical Officer at Promaxo - the company pioneering in-office MRI technology for prostate cancer diagnosis and treatment. With over 25 years of clinical practice, 2,500+ enlarged prostate procedures performed, and a career rooted in bringing advanced imaging technology directly into the urologist's office, Sethi straddles the worlds of clinical medicine and medical device innovation. Trained at UC Berkeley, St. Louis University, and Medical College of Wisconsin, he built Golden State Urology from a single Stockton practice in 2004 into a multi-location Northern California institution, and now serves as a clinical voice for a technology that is reshaping how prostate cancer is caught and treated.
Mehak Aggarwal is the Co-Founder, CPO, and Head of AI at Sybill, an AI-powered sales assistant platform that analyzes sales calls, writes follow-up emails, and updates CRMs automatically. A product of IIT Delhi's dual-degree program in Mathematics and Computing, she went on to conduct research at Harvard's biomedical imaging center (where she developed a patented CT scan fracture-detection algorithm), Hebrew University of Jerusalem, and Singapore University of Technology and Design. She and her co-founders - including her brother Gorish Aggarwal - built Sybill into a 700+ customer platform with $14.6M in total funding. In 2025, she was named a fully funded Knight-Hennessy Scholar at Stanford Graduate School of Business, continuing to lead Sybill while studying.